Effects of high-frequency bio-oxidative ozone therapy in temporomandibular disorder-related pain

Mansur Doğan, Derya Ozdemir Doğan, Cevdet Düger, Iclal Ozdemir Kol, Aysun Akpınar, Burcu Mutaf, Türker Akar, Mansur Doğan, Derya Ozdemir Doğan, Cevdet Düger, Iclal Ozdemir Kol, Aysun Akpınar, Burcu Mutaf, Türker Akar

Abstract

Objective: It was the aim of this study to compare the efficacy of ozone therapy and drug treatment in patients with painful temporomandibular joint (TMJ) disorder (TMD).

Subjects and methods: A total of 63 patients with TMD were enrolled; 33 were treated with bio-oxidative therapy and 30 with a ketoprofen tablet thiocolchicoside capsule 2 × 1 for 7 days. Maximum voluntary interincisal mouth opening (MMO) was measured in millimeters using a scale and recorded during the pre- and posttreatment periods. The patients evaluated their subjective pain using a visual analogue scale (VAS). Data were analyzed using the Mann-Whitney U test, the Kolmogorov-Smirnov test, and the independent t test.

Results: The mean MMO of the group that received ozone therapy during the pretreatment period was 46.51 ± 8.2 mm, and it immediately increased to 48.78 ± 7.5 mm after 1 week of ozone therapy, which was statistically significant (p = 0.04). For those who received medication, the mean MMO during the pretreatment period was 46.30 mm, and at the end of 1 week it was 46.9 mm. In the ozone group, 29% of patients showed a gradual decrease in their VAS pain scores compared to pretreatment values (6.3 ± 2.1 to 3.0 ± 2.2). In the medication group, 24% of patients showed a significant decrease in VAS pain scores during the follow-up period (6.9 ± 1.4 to 5.0 ± 1.5).

Conclusion: This study showed that bio-oxidative therapy was a more effective treatment than medication therapy for relieving TMJ pain.

© 2014 S. Karger AG, Basel.

References

    1. Cairns BE. Pathophysiology of TMD pain – basic mechanisms and their implications for pharmacotherapy. J Oral Rehabil. 2010;37:391–410.
    1. Okeson JP. Management of Temporomandibular Disorders and Occlusion. ed 6. St Louis: Mosby; 2008. pp. 176–189. 413.
    1. Barkin S, Weinberg S. Internal derangements of the TMJ: the role of arthroscopic surgery and arthrocentesis. J Can Dent Assoc. 2000;69:199–203.
    1. Lamontagne P, Al-Tarakemah Y, Honkala E. Relationship between the preferred chewing side and the angulation of anterior tooth guidance. Med Princ Pract. 2013;22:545–549.
    1. Durham J. Temporomandibular disorders (TMD): an overview. Oral Surg. 2008;1:60–68.
    1. Klasser GD, Greene CS. Oral appliances in the management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:212–223.
    1. McNeely ML, Armijo Olivo S, Magee DJ. A systematic review of the effectiveness of physical therapy interventions for temporomandibular disorders. Phys Ther. 2006;86:710–725.
    1. Rahimi-Movaghar V. The major efficient mechanisms of ozone therapy are obtained in intradiscal procedures. Pain Physician. 2012;15:E1007–E1008.
    1. Bocci V, Zanardi I, Travagli V. Has oxygen-ozone therapy a future in medicine? J Exp Integr Med. 2011;1:5–11.
    1. Daif ET. Role of intra-articular ozone gas injection in the management of internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:10–14.
    1. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004;13:3.
    1. Gupta G, Mansi B. Ozone therapy in periodontics. J Med Life. 2012;5:59–67.
    1. Grootveld M, Baysan A, Sidiiqui N, et al. History of the clinical applications of ozone. In: Lynch E, editor. Ozone: The Revolution in Dentistry. London: Quintessence; 2004. pp. 23–30.
    1. Baysan A, Lynch E. Antimicrobial effects of ozone on caries. In: Lynch E, editor. Ozone: The Revolution in Dentistry. London: Quintessence; 2004. pp. 165–172.
    1. Rothchild JA, Harris RE, Mollica PJ. Current concepts of oxygen ozone therapy for dentistry in the United States. Int J Ozone Ther. 2010;9:105–108.
    1. Jakab GJ, Hmieleski RR. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. J Toxicol Environ Health. 1988;23:455–472.
    1. Wolcott JA, Zee YC, Osebold JW. Exposure to ozone reduces influenza disease severity and alters distribution of influenza viral antigens in murine lungs. Appl Environ Microbiol. 1982;44:723–731.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj